Mira Pharmaceuticals Income Statement (2022-2025) | MIRA

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating items
Research & Development (Quarter) 0.71M0.88M0.27M1.02M0.39M0.76M0.61M1.07M0.86M0.31M0.50M0.41M0.50M
Selling, General & Administrative (Quarter) 1.59M0.74M0.05M0.61M1.07M2.14M2.67M1.01M1.12M1.01M1.58M1.49M1.05M0.90M5.33M
Other Operating Expenses (Quarter) 0.83M0.36M0.41M0.45M-0.10M
Operating Expenses (Quarter) 2.42M1.81M1.35M1.34M0.97M3.16M3.06M1.77M1.73M2.08M2.44M1.81M1.55M1.32M5.82M
Non-operating items
Non Operating Investment Income (Quarter) 0.18M-0.21M
Interest & Investment Income (Quarter) 0.04M0.01M
Other Non Operating Income (Quarter) -107.00
Non Operating Income (Quarter) 0.04M0.04M-107.000.18M-0.16M
Net income details
Profit After Tax (Quarter) -2.42M-1.81M-1.35M-1.34M-1.27M-3.59M-5.79M-1.72M-1.69M-2.04M-2.40M-1.78M-1.54M-1.14M-5.94M
Preferred Dividend Payments (Quarter) 21.56M
Net Income towards Common Stockholders (Quarter) -2.04M-2.40M-22.69M-5.98M
Additional items
EPS (Basic) (Quarter) -0.19-0.140.03-0.10-0.10-0.26-0.40-0.15-0.11-0.14-0.15-0.11-0.09-1.180.10
EPS (Weighted Average and Diluted) (Quarter) -0.19-0.140.03-0.10-0.10-0.26-0.40-0.15-0.11-0.14-0.15-0.11-0.09-1.180.10
Shares Outstanding (Weighted Average) (Quarter) 13.09M13.17M17.57M17.75M13.31M0.06M13.92M1.76M14.78M1.76M15.44M16.65M16.99M19.27M23.69M
Shares Outstanding (Diluted Average) (Quarter) 13.09M13.17M17.57M17.75M13.31M13.64M13.92M14.78M14.78M15.07M15.44M16.65M16.99M19.27M
Interest Expenses (Quarter) 0.00M0.00M0.00M0.00M0.30M0.43M3.48M-0.05M-0.04M-0.04M-0.02M0.01M396.00